Article Type: Generic

A new report from the CD Howe Institute slams labour-sponsored venture capital corporations (LSVCCs) and calls for government to end their tax subsidies in favour of other mechanisms for stimulating the growth of innovative firms.

$103 million in latest round

The Ontario government has announced more funding targeting research infrastructure and talent as it considers the optimal time for releasing its research and innovation strategy before this October’s provincial election.

The Stem Cell Network (SCN) has entered into a collaborative agreement with the MaRS Discovery District to transfer control of its nascent spin-off commercialization arm, Aggregate Therapeutics Inc (ATI).

Aggregate Therapeutics Inc’s (ATI) novel approach to intellectual property management of stem cell technologies has produced its first company spin-off. Regium is composed of several licensed and optioned technologies from Canadian institutions represented by ATI, which will benefit from the recently concluded partnership with MaRS Discovery District.

Sights set on new federal program

The Centre for Drug Research and Development (CDRD) is nearing the halfway mark of its $100-million fundraising goal with the decision by the British Columbia government to provide a $25-million grant to support its operations.

The Centre for Drug Research and Development (CDRD) has scored a modest but important victory with the success of Dr Sandra Dunn in the latest competition of the Canadian Institutes of Health Research’s (CIHR) Proof of Principle program.

The British Columbia government is hoping to lever $450 million in new venture capital (VC) with a commitment of $90 million to create the BC Renaissance Capital Fund (BCRCF). The new Fund is considered a turning point in the province’s ongoing challenge to encourage new investment and R&D in the homegrown high tech sector and expand the talent pool.

The success or failure of a handful of late-stage clinical trials or product approvals could determine the future financing success of early-stage and public Canadian biotechnology companies, according to a new report.

Nearly nine years after pledging to invest in the Rotman School of Management, the Ontario government has followed through with a $50-million commitment to the Centre for Jurisdictional Advantage and Prosperity (CJAP).

Canada is taking the first step towards establishing a network of bi-national collaborative R&D programs modeled on its successful collaboration with Israel. International Science and Technology Partnerships Canada (ISTPCanada) has been selected to implement a $20-million program over five years to support bilateral R&D with Israel, India, China and Brazil.